Invention Grant
- Patent Title: Dihydropyrazole GPR40 modulators
-
Application No.: US14442624Application Date: 2013-11-15
-
Publication No.: US09656963B2Publication Date: 2017-05-23
- Inventor: Andres S. Hernandez , Bruce A. Ellsworth , William R. Ewing , Bin Chen
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Barry H. Jacobsen; Yong Lu
- International Application: PCT/US2013/070209 WO 20131115
- International Announcement: WO2014/078608 WO 20140522
- Main IPC: C07D231/06
- IPC: C07D231/06 ; C07D403/12 ; C07D231/08 ; C07D401/10 ; C07D403/04 ; C07D401/04 ; C07D401/12 ; C07D403/10 ; C07D413/04 ; A61K45/06 ; A61K31/4155 ; A61K31/415 ; A61K31/506 ; A61K31/497 ; A61K31/422 ; A61K31/4439
Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Public/Granted literature
- US20160280659A1 DIHYDROPYRAZOLE GPR40 MODULATORS Public/Granted day:2016-09-29
Information query
